Published on 22 June, 2026
The Indian Union Ministry of Health and Family Welfare (MoHFW) has prohibited the manufacture, sale, and distribution of 16 fixed-dose combination (FDC) drugs for human use. The ban applies to several antibiotic-based formulations, pain-relief and antispasmodic combinations, and topical skincare products that regulators found to lack adequate therapeutic justification.
This article explains what fixed-dose combination drugs are, why some of such combinations are useful, why irrational combinations may pose health risks, and which drug combinations have recently been banned in India.
What Are Fixed-Dose Combination (FDC) Drugs?
If you read the ingredients listed on a tablet, syrup, capsule, or inhaler, you may notice that some medicines contain more than one active ingredient. These are known as fixed-dose combination drugs. An FDC is a medicine that contains two or more active pharmaceutical ingredients in a fixed ratio within a single dosage form.
A rational FDC provides a clear therapeutic benefit. For example, instead of taking two separate medicines, a patient may be prescribed one combined pill, which can make treatment simpler and improve adherence to the prescribed schedule. However, for an FDC to be justified, every ingredient must be necessary, safe, effective, and included at the right dose.
Why Were These FDC Drugs Banned in India?
The government banned 16 FDCs because they were considered irrational combinations. In practical terms, this means the combinations did not show sufficient medical benefit, lacked therapeutic justification, or could expose patients to unnecessary risks. The ban was issued under Section 26A of the Drugs and Cosmetics Act, 1940, as part of efforts to promote rational medicine use and improve patient safety.
Below are the major categories of banned fixed-dose combination drugs and examples of the prohibited formulations.
Banned Antibiotic-Based FDCs
Some of the banned formulations combine antibiotics with enzymes or probiotics. These include:
- Amoxicillin + Serratiopeptidase
- Amoxicillin + Serratiopeptidase + Lactobacillus Sporogenes
- Amoxicillin + Cloxacillin + Lactic Acid Bacillus + Serratiopeptidase
- Cefuroxime + Serratiopeptidase
- Cefadroxyl + Probenecid
In these formulations, amoxicillin, cloxacillin, cefuroxime, and cefadroxyl are antibiotics. Serratiopeptidase is an enzyme sometimes used with the aim of reducing inflammation, while probiotics such as lactic acid bacillus may be used to support gut flora during antibiotic therapy. However, regulators found that these fixed combinations lacked sufficient therapeutic justification when used in single pills and were therefore prohibited.
Banned Analgesic and Antispasmodic Combinations
The banned pain-relief and antispasmodic formulations include:
- Dicyclomine + Paracetamol + Clidinium Bromide
- Dicyclomine + Paracetamol + Clidinium Bromide + Chlordiazepoxide
- Acetyl Salicylic Acid (Aspirin) + Ethoheptazine
- Paracetamol + Lignocaine
Medicines such as aspirin and paracetamol are commonly used for pain and fever, while drugs such as dicyclomine and clidinium bromide reduce spasms. Combining these ingredients in a fixed dose may not provide additional benefit and may increase the risk of side effects.
Banned Skin Formulations
Several skincare formulations were also included in the ban. Examples include:
- Aloe Extract + Allantoin + Alpha Tocopherol Acetate (Vitamin E) + D-Panthenol + Vitamin A
- Aloe Vera + Jojoba Oil + Wheat Germ Oil + Tea Tree Oil
- Aloe Extract + Vitamin E + Dimethicone + Glycerine
- Aloe Vera + Orange Oil (and related permutations)
These combinations may not have adequate scientific evidence to prove that the fixed formulation provides a clear therapeutic advantage. As a result, they were included among the banned FDCs.
What Should Patients Do?
Patients should not stop or change any prescribed medicine without consulting a qualified healthcare professional. If you are using a medicine that contains any of the banned combinations, speak to your doctor or pharmacist about safer and approved alternatives.
Key Takeaway
Fixed-dose combination drugs can be beneficial when they are scientifically justified and prescribed appropriately. However, irrational FDCs may expose patients to unnecessary medicines, increase side effects, and contribute to unsafe or ineffective treatment. India’s ban on 16 fixed-dose combination drugs highlights the importance of evidence-based prescribing and rational medicine use.
Reference
Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. Fixed Dose Combination.
Disclaimer: The information provided in this site is for informational purposes only. It is not intended to replace the advice of a doctor or healthcare professional, or the relationship that exists between a patient/site visitor and his/her existing physician. Always consult your doctor or other qualified healthcare provider for any medical condition, procedure, or treatment.